RxSight Inc.

NASDAQ: RXST · Real-Time Price · USD
8.27
0.05 (0.61%)
At close: Aug 15, 2025, 11:47 AM

RxSight Statistics

Share Statistics

RxSight has 40.64M shares outstanding. The number of shares has increased by 2.4% in one year.

40.64M
2.4%
0.36%
89.57%
37.98M
26
n/a

Short Selling Information

The latest short interest is 4.96M, so 12.2% of the outstanding shares have been sold short.

4.96M
12.2%
12.81%
1.56

Valuation Ratios

The PE ratio is -48.67 and the forward PE ratio is -6.74. RxSight's PEG ratio is 0.98.

-48.67
-6.74
9.55
2
4.75
-59.69
0.98
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for RxSight.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 11.36, with a Debt / Equity ratio of 0.04.

11.36
10.5
0.04
-0.52
-0.55
-1755.14

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$280.98K
$-55.13K
498
0.44
1.86

Taxes

50K
-0.18%

Stock Price Statistics

The stock price has increased by -87.27% in the last 52 weeks. The beta is 1.15, so RxSight's price volatility has been higher than the market average.

1.15
-87.27%
11.18
25.77
28.7
1,277,512

Income Statement

In the last 12 months, RxSight had revenue of 139.93M and earned -27.45M in profits. Earnings per share was -0.71.

139.93M
98.94M
-36.86M
-27.45M
-23.76M
-27.38M
-0.71
Full Income Statement

Balance Sheet

The company has 16.71M in cash and 12.3M in debt, giving a net cash position of 4.41M.

16.71M
12.3M
4.41M
-622.1M
313.04M
265.67M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.95M and capital expenditures -5.44M, giving a free cash flow of -22.39M.

-16.95M
-5.44M
-22.39M
-0.58
Full Cash Flow Statement

Margins

Gross margin is 70.71%, with operating and profit margins of -26.34% and -19.62%.

70.71%
-26.34%
-19.59%
-19.62%
-16.98%
-26.34%
-16%

Dividends & Yields

RXST does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for RXST is $9, which is 35.5% higher than the current price. The consensus rating is "Hold".

$9
35.5%
Hold
10
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

3.63
3